MENU
ALGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ALGN stock forecast, quote, news & analysis

Align Technology is the leading manufacturer of clear aligners... Show more

ALGN
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
a Summary for ALGN with price predictions
Sep 22, 2026

ALGN sees its Stochastic Oscillator recovers from oversold territory

On September 22, 2026, the Stochastic Oscillator for ALGN moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 58 instances where the indicator left the oversold zone. In 48 of the 58 cases the stock moved higher in the following days. This puts the odds of a move higher at over 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ALGN's RSI Indicator exited the oversold zone, 27 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.

The Moving Average Convergence Divergence (MACD) for ALGN just turned positive on September 22, 2026. Looking at past instances where ALGN's MACD turned positive, the stock continued to rise in 30 of 43 cases over the following month. The odds of a continued upward trend are 70%.

Following a +1.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALGN advanced for three days, in 194 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.

ALGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ALGN as a result. In 57 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.

ALGN moved below its 50-day moving average on August 17, 2026 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for ALGN moved below the 200-day moving average on September 09, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

The Aroon Indicator for ALGN entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 28 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. ALGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.573) is normal, around the industry mean (4.961). P/E Ratio (26.613) is within average values for comparable stocks, (161.442). Projected Growth (PEG Ratio) (0.646) is also within normal values, averaging (4.443). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.612) is also within normal values, averaging (56.074).

The Tickeron SMR rating for this company is 69 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 8.62B. The market cap for tickers in the group ranges from 126 to 141.89B. ISRG holds the highest valuation in this group at 141.89B. The lowest valued company is HGYMF at 126.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 2%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 20%. BNGO experienced the highest price growth at 17%, while CUPR experienced the biggest fall at -32%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -28%. For the same stocks of the Industry, the average monthly volume growth was 45% and the average quarterly volume growth was 1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 59
Price Growth Rating: 53
SMR Rating: 81
Profit Risk Rating: 95
Seasonality Score: -47 (-100 ... +100)
View a ticker or compare two or three
ALGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a manufacturer of the invisalign system for treating malocclusion

Industry PharmaceuticalsOther

Industry
Medical Specialties
Address
410 North Scottsdale Road
Phone
+1 602 742-2000
Employees
20290
Web
https://www.aligntech.com
ALGN sees its Stochastic Oscillator recovers from oversold territory